143 related articles for article (PubMed ID: 20851941)
1. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
3. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
[TBL] [Abstract][Full Text] [Related]
4. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
Narquin S; Ingrand P; Azais I; Delwail V; Vialle R; Boucebci S; Tasu JP
Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
[TBL] [Abstract][Full Text] [Related]
5. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
6. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Bäuerle T; Hillengass J; Fechtner K; Zechmann CM; Grenacher L; Moehler TM; Christiane H; Wagner-Gund B; Neben K; Kauczor HU; Goldschmidt H; Delorme S
Radiology; 2009 Aug; 252(2):477-85. PubMed ID: 19703885
[TBL] [Abstract][Full Text] [Related]
7. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
8. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
11. The Role of
Deng S; Zhang B; Zhou Y; Xu X; Li J; Sang S; Zhang W
Contrast Media Mol Imaging; 2018; 2018():4198673. PubMed ID: 30154686
[TBL] [Abstract][Full Text] [Related]
12. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of the spine in plasma cell dyscrasias. A review.
Pertuiset E; Bellaiche L; Lioté F; Laredo JD
Rev Rhum Engl Ed; 1996 Dec; 63(11):837-45. PubMed ID: 9010972
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
[TBL] [Abstract][Full Text] [Related]
15. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
Durie BG
Eur J Cancer; 2006 Jul; 42(11):1539-43. PubMed ID: 16777405
[TBL] [Abstract][Full Text] [Related]
16. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy.
Dinter DJ; Neff WK; Klaus J; Böhm C; Hastka J; Weiss C; Schoenberg SO; Metzgeroth G
Ann Hematol; 2009 May; 88(5):457-64. PubMed ID: 18941746
[TBL] [Abstract][Full Text] [Related]
17. Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables--diagnostic and prognostic significance.
Ffrench M; Ffrench P; Remy F; Chapuis-Cellier C; Wolowiec D; Ville D; Bryon PA
Am J Med; 1995 Jan; 98(1):60-6. PubMed ID: 7825620
[TBL] [Abstract][Full Text] [Related]
18. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
[TBL] [Abstract][Full Text] [Related]
19. Imaging of multiple myeloma and related plasma cell dyscrasias.
Walker RC; Brown TL; Jones-Jackson LB; De Blanche L; Bartel T
J Nucl Med; 2012 Jul; 53(7):1091-101. PubMed ID: 22693310
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]